Search results
Showing 61 to 75 of 165 results for metastatic breast cancer
Breast cancer (locally advanced or metastatic) - ixabepilone [ID377]
Discontinued [GID-TAG403]
Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)
Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.
Awaiting development [GID-TA11339] Expected publication date: TBC
Find out about the progress made by the health and care system in implementing NICE guidance on prostate cancer
In development [GID-NG10415] Expected publication date: TBC
Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.
This webpage covers NICE guidelines on breast cancer. The table below presents the guidelines alphabetically with links to...
In development [GID-NG10419] Expected publication date: 31 March 2025
Caris Molecular Intelligence for guiding cancer treatment (MIB120)
NICE has developed a medtech innovation briefing (MIB) on Caris Molecular Intelligence for guiding cancer treatment .
Topotecan for the treatment of recurrent and stage IVB cervical cancer (TA183)
Evidence-based recommendations on topotecan for treating recurrent and stage IVB cervical cancer in adults.